|  | Prostate cancer n (%) | BPH n (%) |
---|---|---|---|
Age | < 60 | 17 (16.5) | 26 (26) |
60–69 | 37 (35.9) | 41 (41) | |
≥70 | 49 (47.6) | 33 (33) | |
PSA (ng/ml) | ≤4 | 13 (12.6) | 19 (19) |
4.1–10 | 47 (45.6) | 56 (56) | |
> 10 | 43 (41.7) | 25 (25) | |
Gleason score | < 7 | 14 (13.6) | – |
7 | 47 (45.6) | – | |
≥8 | 42 (40.8) | – | |
Perineural invasion | + | 65 (63.1) | – |
– | 38 (36.9) | – | |
Extra prostatic extension | + | 18 (17.5) | – |
– | 85 (82.5) | – |